IGHV1-67: Unlocking The Potential of An Immunoglobulin Target

Target Name: IGHV1-67

NCBI ID: G28463

IGHV1-67

Other Name(s): Immunoglobulin heavy variable 1-67 (pseudogene) | 1-67P | immunoglobulin heavy variable 1-67 (pseudogene) | IGHV167

IGHV1-67: Unlocking The Potential of An Immunoglobulin Target

IGHV1-67 (Immunoglobulin heavy variable 1-67 (pseudogene)) is a protein that is expressed in various tissues throughout the body, including the liver, spleen, and Peyer's patches of the small intestine. It is a member of the immunoglobulin family, which consists of five classes of antibodies: IgA, IgD, IgE, IgG, and IgM.

IGHV1-67 is a large protein that contains multiple functional regions, including a constant region, a variable region, and an acidic tail region. The constant region is the region of the protein that is constant between different isotypes, while the variable region is the region of the protein that is variable between different isotypes. The acidic tail region is the region at the end of the protein that contains a negatively charged carboxylic acid residue, which is involved in protein-protein interactions and can modulate the protein's stability and interactions with other molecules.

IGHV1-67 has been shown to play a role in various physiological processes in the body. For example, it is involved in the immune response, as it is a component of antibodies that are produced by B cells in response to the presence of foreign substances in the body. It is also involved in the regulation of inflammation, as it has been shown to play a role in the production of pro-inflammatory cytokines.

In addition to its role in the immune response and inflammation, IGHV1-67 has also been shown to be involved in the regulation of cell signaling processes. For example, it has been shown to play a role in the regulation of cell adhesion, as it is a component of the protein complex that is involved in cell-cell adhesion. It is also involved in the regulation of cell signaling processes, as it has been shown to play a role in the signaling pathway that is responsible for the regulation of cell proliferation and apoptosis.

As a potential drug target, IGHV1-67 is an attractive target for research because of its involvement in various physiological processes in the body. It is also a protein that is expressed in a variety of tissues throughout the body, which makes it an attractive target for research because it is likely to be involved in a wide range of physiological processes. Additionally, because IGHV1-67 is a pseudogene, which means that it is a genetic copy of a gene that already exists in the genome, it is relatively easy to study and manipulate.

In conclusion, IGHV1-67 is a protein that is involved in various physiological processes in the body, including the immune response and inflammation. It is also involved in the regulation of cell signaling processes, and as a potential drug target, it is an attractive target for research because of its involvement in a wide range of physiological processes. Further research is needed to fully understand the role of IGHV1-67 in the immune response and inflammation, as well as its potential as a drug target.

Protein Name: Immunoglobulin Heavy Variable 1-67 (pseudogene)

The "IGHV1-67 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHV1-67 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets